Home
Knowledge Center

Knowledge Center

The latest insights, news, events and webinars from Phastar

The Cutting Edge of Biometrics

Keep up-to-date with the latest trends and developments with insights from our biostatisticians, programmers, and data scientists.

Press Releases

Phastar Scoops Multiple Finalist Positions in 2025 Scrip Awards

October 1st, 2025 3 minute read

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as fi...

Press Releases

Phastar Appoints Industry Veteran Billy Amzal as Head of Strategic Consulting

June 24th, 2025 2 minute read

London, UK, and Durham (NC), US – June 24th, 2025: Phastar, a global specialist biometrics & data science Contrac...

Press Releases

Phastar Secures Finalist Spot at 2025 Citeline Awards

April 10th, 2025 3 minute read

London, UK, and Durham (NC), US – April 10th, 2025: Phastar, a global specialist biometrics & data science Contra...

View all

Events

Meet Phastar at PHUSE US Connect 2026

November 17th, 2025 1 minute read

Phastar is delighted to be exhibiting at PHUSE US Connect in Austin Texas, from 22nd – 26th March 2026.

Events

Meet Phastar at PHUSE APAC Connect 2026

November 17th, 2025 1 minute read

Phastar is delighted to be exhibiting at PHUSE APAC Connect in Hyderabad, India from 19th – 21st February 2026.

Events

Meet Phastar at PSI 2026

November 17th, 2025 1 minute read

Phastar is delighted to be exhibiting at PSI in Belfast from 15th – 17th June 2026. Visit the Phastar team at B...

View all

Webinars

SDTM Workflow Transformation: Faster, Easier and More Reliable

November 14th, 2025 1 minute read

The demand for rapid, cost-effective, and standards-compliant SDTM delivery continues to increase across the biotech ...

Webinars

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls

November 5th, 2025 1 minute read

Use of external data to augment clinical trials has been increasingly evaluated and is transforming drug development ...

Webinars

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

October 30th, 2025 1 minute read

The early stages of clinical development are critical, decisions made here can determine the efficiency, cost, and ul...

View all

Case Studies

Delivering a Complex Integrated Summary of Effectiveness: Efficient Pooling and Advanced Analysis Across Four Multiple Sclerosis Spasticity Studies

November 17th, 2025 1 minute read

A sponsor needed to pool data from four MS spasticity studies—one still ongoing with another vendor—while adapting mi...

Case Studies

IDAC for a Phase III Study in Thrombotic Microangiopathy: Delivering High-Quality Statistical Support Within Budget Constraints

November 12th, 2025 1 minute read

Phastar acted as the Independent Data Analysis Centre (IDAC) for a Phase III trial in thrombotic microangiopathy (TMA...

Case Studies

Delivering an Integrated Summary of Safety: Resolving Data Inconsistencies and Complex Derivations to Support Regulatory Submission

October 22nd, 2025 1 minute read

Phastar supported a sponsor in preparing an Integrated Summary of Safety (ISS) for an investigational drug in sickle ...

View all

Articles & Interviews

Why ‘Good Enough’ is Not Acceptable in CRO Partnerships

November 11th, 2025 1 minute read

As clinical trials grow increasingly complex, sponsors are turning to specialist CROs with the expertise to transform...

Articles & Interviews

Utilizing Tech Tools to Accelerate Drug Development

November 6th, 2025 1 minute read

The adoption of advanced technological tools in clinical trials is accelerating as sponsors seek faster insights, str...

Articles & Interviews

Specialist Data-Focused CROs: The Partnership Solution for Modern Clinical Trials

August 27th, 2025 1 minute read

Outsourcing clinical trial activities to specialist data-focused CROs is growing rapidly, driven by the need for expe...

View all

Blogs

Meet the Team: Alice Spencer, Senior Statistician

November 6th, 2025 3 minute read

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each te...

Blogs

The Need for a DMC and the Operational Role of an Independent Data Analysis Center: Practical Insights for Sponsors

November 4th, 2025 5 minute read

Introduction Data Monitoring Committees (DMCs) play a pivotal role in protecting the rights, safety and well-being o...

Blogs

The Rise of Innovative Trial Designs in Rare Disease Research

October 28th, 2025 6 minute read

By Billy Amzal, Head of Strategic Consulting, Phastar Introduction Rare disease research demands tailored...

View all

Publications

Advancing Clinical Trial Design with Bayesian Statistics and Prior Elicitation

April 1st, 2025 1 minute read

Discover how Bayesian statistics can enhance clinical trial efficiency and improve decision-making. Our latest white ...

Publications

Unlock the Power of Real-World Evidence in Clinical Research

February 25th, 2025 1 minute read

Discover how Real-World Evidence (RWE) is revolutionizing drug development and clinical decision-making in our latest...

Publications

A Strategic Approach to Project Optimus: Key Considerations for Oncology Trials

October 10th, 2024 1 minute read

As oncology drug development continues to evolve, the FDA’s Project Optimus is reshaping how clinical trials ap...

View all

Knowledge Center

The Cutting Edge of Biometrics

Press Releases

Phastar Scoops Multiple Finalist Positions in 2025 Scrip Awards

Phastar Appoints Industry Veteran Billy Amzal as Head of Strategic Consulting

Phastar Secures Finalist Spot at 2025 Citeline Awards

Events

Meet Phastar at PHUSE US Connect 2026

Meet Phastar at PHUSE APAC Connect 2026

Meet Phastar at PSI 2026

Webinars

SDTM Workflow Transformation: Faster, Easier and More Reliable

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

Case Studies

Delivering a Complex Integrated Summary of Effectiveness: Efficient Pooling and Advanced Analysis Across Four Multiple Sclerosis Spasticity Studies

IDAC for a Phase III Study in Thrombotic Microangiopathy: Delivering High-Quality Statistical Support Within Budget Constraints

Delivering an Integrated Summary of Safety: Resolving Data Inconsistencies and Complex Derivations to Support Regulatory Submission

Articles & Interviews

Why ‘Good Enough’ is Not Acceptable in CRO Partnerships

Utilizing Tech Tools to Accelerate Drug Development

Specialist Data-Focused CROs: The Partnership Solution for Modern Clinical Trials

Blogs

Meet the Team: Alice Spencer, Senior Statistician

The Need for a DMC and the Operational Role of an Independent Data Analysis Center: Practical Insights for Sponsors

The Rise of Innovative Trial Designs in Rare Disease Research

Publications

Advancing Clinical Trial Design with Bayesian Statistics and Prior Elicitation

Unlock the Power of Real-World Evidence in Clinical Research

A Strategic Approach to Project Optimus: Key Considerations for Oncology Trials

Speak to our Team of Experts